Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4A | O75164 | 4/20 | 0.56 |
| ▸ | KDM2A | Q9Y2K7 | 4/20 | 0.56 |
| ▸ | MAPT | P10636 | 5/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | HTT | P42858 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | CASP1 | P29466 | 2/20 | 0.54 |
| ▸ | HBB | P68871 | 2/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.54 |
| ▸ | CASP7 | P55210 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | ALPG | P10696 | 1/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.54 |
| ▸ | GFER | P55789 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | RELA | Q04206 | 1/20 | 0.51 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18349216 | 0.88 | KDM4A (0.56) | KDM4AKDM2AMAPTSMN1; SMN2KMT2A | |
| SCHEMBL19860017 | 0.86 | MEN1 (0.57) | KDM4AKDM2AMAPTSMN1; SMN2KMT2A | |
| SCHEMBL15797226 | 0.86 | KDM4A (0.58) | KDM4AKDM2AMAPTSMN1; SMN2KMT2A | |
| SCHEMBL15797224 | 0.86 | KDM4A (0.58) | KDM4AKDM2AMAPTSMN1; SMN2KMT2A | |
| Bromide SCHEMBL17221056 | 0.85 | KDM4A (0.57) | KDM4AKDM2AMAPTSMN1; SMN2KMT2A | |
| SCHEMBL19519178 | 0.85 | CHRM2 (0.54) | KDM4AKDM2AMAPTSMN1; SMN2KMT2A | |
| SCHEMBL19506338 | 0.85 | CHRM2 (0.54) | KDM4AKDM2AMAPTSMN1; SMN2KMT2A | |
| Bromide SCHEMBL17221057 | 0.85 | KDM4A (0.57) | KDM4AKDM2AMAPTSMN1; SMN2KMT2A | |
| Hydrochloric Acid SCHEMBL19469279 | 0.84 | CHRM2 (0.53) | KDM4AKDM2AMAPTSMN1; SMN2KMT2A | |
| Hydrochloric Acid SCHEMBL19469278 | 0.84 | CHRM2 (0.53) | KDM4AKDM2AMAPTSMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180170953-A1 | PROTOTYPE SYSTEMS OF THERANOSTIC BIOMARKERS FOR IN VIVO MOLECULAR MANAGEMENT OF CANCER | EPOS-IASIS RESEARCH AND DEVELOPMENT, LTD (CY) | 2018-06-21 | — | — | US | disclosed |
| US-20160376298-A1 | PROTOTYPE SYSTEMS OF THERANOSTIC BIOMARKERS FOR IN VIVO MOLECULAR MANAGEMENT OF CANCER | EPOS-IASIS RESEARCH AND DEVELOPMENT, LTD (CY) | 2016-12-29 | — | — | US | disclosed |
| US-8723017-B2 | Dye sensitised solar cell | BASF SE (DE) | 2014-05-13 | — | — | US | disclosed |
| US-8709299-B2 | Dye sensitised solar cell | BASF SE (DE) | 2014-04-29 | — | — | US | disclosed |
| EP-2253031-B1 | DYE SENSITISED SOLAR CELL | BASF SE (DE) | 2012-10-17 | — | — | EP | disclosed |
| US-20120145238-A1 | DYE SENSITISED SOLAR CELL | BASF SE (DE) | 2012-06-14 | — | — | US | disclosed |
| US-20110061723-A1 | DYE SENSITISED SOLAR CELL | BASF SE (DE) | 2011-03-17 | — | — | US | disclosed |
| WO-2009109499-A1 | DYE SENSITISED SOLAR CELL | BASF SE (DE) | 2009-09-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120145238-A1 | DYE SENSITISED SOLAR CELL | FTO, TET1, METTL14 | KDM4A 303/4885KDM2A 394/4885MAPT 1981/4885 |
| US-20110061723-A1 | DYE SENSITISED SOLAR CELL | FTO, TET1, METTL14 | KDM4A 303/4885KDM2A 394/4885MAPT 1981/4885 |
| US-20160376298-A1 | PROTOTYPE SYSTEMS OF THERANOSTIC BIOMARKERS FOR IN VIVO MOLECULAR MANAGEMENT OF CANCER | TP53, MKI67, FLT3 | KDM4A 1575/4885KDM2A 2114/4885MAPT 4308/4885 |
| US-20180170953-A1 | PROTOTYPE SYSTEMS OF THERANOSTIC BIOMARKERS FOR IN VIVO MOLECULAR MANAGEMENT OF CANCER | TP53, MKI67, FLT3 | KDM4A 1575/4885KDM2A 2114/4885MAPT 4308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.